Fibril formation by amyloid-β proteins may involve β-helical protofibrils

被引:19
|
作者
Lazo, ND [1 ]
Downing, DT [1 ]
机构
[1] Univ Iowa, Marshall Res Labs, Dept Dermatol, Coll Med, Iowa City, IA 52242 USA
来源
JOURNAL OF PEPTIDE RESEARCH | 1999年 / 53卷 / 06期
关键词
amyloid-beta; Alzheimer's disease; beta-helix; protofibrils;
D O I
10.1034/j.1399-3011.1999.00057.x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have proposed that amyloid fibrils contain subunits (protofibrils) that are formed from beta-strands wound into continuous 2-3 nm-diameter beta-helices. Subsequent lateral aggregation of the beta-helices to form the widely observed 5-12 nm-diameter fibrils could be promoted by hydrophobic residues on the exterior of the postulated beta-helix. A number of short peptide fragments of the amyloid-beta (A beta) proteins, such as A beta 34-42 [LMVGGVVIA], the nine-residue, carboxyl-terminal portion of A beta 1-42, can also form amyloid fibrils. In the present study, ii was found that a beta-helix formed from A beta 34-42 accounts for features suggested by published rotational resonance solid-state NMR data, including an anomalous conformation about the Gly-37-Gly-38 region and exaggerated pleating. An analogue of A beta 34-42 was synthesized in which the hydrophobic groups on the exterior of the postulated beta-helix were replaced with glutamates, giving LEVGGVEIE. The analogue was completely soluble at pH 7, but at pH 2.5 it produced 2-2.5 nm-diameter fibrils which did not associate into larger-diameter bundles. The results of this study support the proposal that amyloid fibrils are formed from beta-helical subunits.
引用
收藏
页码:633 / 640
页数:8
相关论文
共 50 条
  • [21] Inhibition of Amyloid-β Fibril Formation and Its Cytotoxicity by Antioxidant-Conjugated Amyloid-β C-Terminal Peptides
    Arai, Takuya
    Ohno, Akiko
    Ozawa, Toshihiko
    Kurihara, Masaaki
    Miyaki, Naoki
    Nakagawa, Hidehiko
    Fukuhara, Kiyoshi
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S157 - S157
  • [22] Probing amyloid-β protofibrils with a conformation-selective antibody
    Nichols, M.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 217 - 218
  • [23] Amyloid fibril proteins
    Xing, YM
    Higuchi, K
    MECHANISMS OF AGEING AND DEVELOPMENT, 2002, 123 (12) : 1625 - 1636
  • [24] Oligomerization and fibril assembly of the amyloid-β protein
    Roher, AE
    Baudry, J
    Chaney, MO
    Kuo, YM
    Stine, WB
    Emmerling, MR
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01): : 31 - 43
  • [25] The Mechanism of Amyloid-β42 Fibril Elongation
    Gurry, Thomas
    Stultz, Collin M.
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 482A - 482A
  • [26] Prevention of Amyloid-β Fibril Formation Using Antibodies Against the C-terminal Region of Amyloid-β1-40 and Amyloid-β1-42
    Montanes, Maria
    Casabona, Diego
    Sarasa, Leticia
    Pesini, Pedro
    Sarasa, Manuel
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (01) : 133 - 137
  • [27] Mechanisms of amyloid formation from Aβ protofibrils
    Nichols, MR
    Moss, MA
    Reed, DK
    Rosenberry, TL
    FASEB JOURNAL, 2001, 15 (05): : A1173 - A1173
  • [28] AMYLOID FIBRIL FORMATION
    COLACO, CALS
    HARRINGTON, CR
    BIO-TECHNOLOGY, 1994, 12 (09): : 848 - 849
  • [29] Serpin acceleration of amyloid fibril formation: A role for accessory proteins
    Powers, Glenn A.
    Pham, Chi L. L.
    Pearce, Mary C.
    Howlett, Geoffrey J.
    Bottomley, Stephen P.
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 366 (02) : 666 - 676
  • [30] Development of a New Distyrylbenzene-Derivative Amyloid-β-aggregation and Fibril Formation Inhibitor
    Suzuki, Hideharu
    Ishigami, Akihito
    Orimoto, Ayako
    Matsuyama, Akihiro
    Handa, Setsuko
    Maruyama, Naoki
    Yokoyama, Yuusaku
    Okuno, Hiroaki
    Nakakoshi, Masamichi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2012, 60 (09) : 1164 - 1170